Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 430-380-7 | CAS number: 445409-27-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted according to OECD Guideline under GLP conditions.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Existing, non-LLNA, data available for this end point.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- Twenty-one female albino Dunkin Hartley guinea pigs supplied by David Hall Limited were used. At the start of the main study the animals weighed 322 to 383 g, and were approx 8 to 12 wks old. After an acclimisation period of at least five days, each animal was selected at random and given a number unique within the study which was written on a small area of clipped rum using a black indelible marker-pen. Animals were housed singly or in pairs in cages. Free access to tap water and food was allowed throughout the study. Animal room was maintained at 19 to 22 degrees C and relative humidity of 42 to 61%. 15 air changes per hour and lighting was controlled by a time switch to give 12 hour continuous light and darkness.
- Route:
- intradermal and epicutaneous
- Vehicle:
- unchanged (no vehicle)
- Remarks:
- also with liquid paraffin BP
- Concentration / amount:
- Intradermal Induction: 1% w/v in liquid paraffin BP; 1% w/v in a mixture of Freund's Complete Adjuvant plus distilled water (1:1)
Topical Induction: undiluted as supplied
Topical Challenge: 75% and 50% v/v in liquid paraffin BP - Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Remarks:
- also with liquid paraffin BP
- Concentration / amount:
- Intradermal Induction: 1% w/v in liquid paraffin BP; 1% w/v in a mixture of Freund's Complete Adjuvant plus distilled water (1:1)
Topical Induction: undiluted as supplied
Topical Challenge: 75% and 50% v/v in liquid paraffin BP - No. of animals per dose:
- Ten test and five control animals (Total 15)
- Details on study design:
- Two main phases were involved in the Main Study; (1) an induction of a response and (b) a challenge of that response.
A row of three injections (0.1 ml each ) was made on each side of the mid-line. The injections were: a) Freund's Complete Adjuvant plus distilled water in the ratio 1:1; b) a 1% w/v emulsion of the test material in liquid paraffin BP; c) a 1% w/v emulsion of the test material in a 1:1 preparation of Freund's Complete Adjuvant plus distilled water.
Approximately 24 and 48 hrs after intradermal injection the degree of erythema at the test material injection sites (injection site b) was evaluated according to scale. One week later the shoulder region used previously for intradermal injections was clipped again and treated with a topical application of the undiluted test material. A filter paper patch was applied to the skin and held in place with surgical tape covered with an overlapping length of aluminum foil. The patch and foil were further secured with a strip of elastic bandage. The occlusive dressing was kept in place for 48 hours. Degree of erythema and oedema was quantified one and 24 hrs following removal of the patches. Other reactions were also recorded. - Challenge controls:
- Controls: Identical procedure to that used for the test animals except that injections were: a) Freund's Complete Adjuvant plus distilled water in the ratio 1:1; b) liquid paraffin BP; c) a 50% w/v formulation of liquid paraffin BP in Freund's Complete Adjuvant/distilled water. The topical application followed the same procedure except that nothing was applied to the filter paper.
Challenge: Shortly before treatment day 21, both flanks of each animal was clipped free of hair with veterinary clippers. A square filter patch was loaded with the maximum non-irritant concentration (75% v/v in liquid paraffin BP) and applied to the shorn right flank of each animal and was held in place by surgical adhesive tape. To ensure that the maximum non-irritant concentration was used at challenge, the test material at a concentration of 50% v/v in liquid paraffin BP was similarly applied to a skin site on the left shorn flank. The patches were occluded with an overlapping length of aluminum foil and secured with a strip of elastic adhesive bandage. After 24 hours the dressing was carefully removed and discarded. The challenge sites were swabbed with cotton wool soaked in diethyl ether to remove residual material. The position of the treatment sites was identified by using a black indelible marker.
Approximately 24 and 48 hours after challenge dressing removed, the degree of erythema and oedema was quantified according to scale. Other reactions were also recorded. - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 15
- Clinical observations:
- None
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50% v/v. No with. + reactions: 0.0. Total no. in groups: 15.0. Clinical observations: None.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 75% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 15
- Clinical observations:
- brown/green coloured staining
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 75% v/v. No with. + reactions: 0.0. Total no. in groups: 15.0. Clinical observations: brown/green coloured staining.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 15
- Clinical observations:
- None
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50% v/v. No with. + reactions: 0.0. Total no. in groups: 15.0. Clinical observations: None.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 75% v/v
- No. with + reactions:
- 0
- Total no. in group:
- 15
- Clinical observations:
- brown/green coloured staining
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 75% v/v. No with. + reactions: 0.0. Total no. in groups: 15.0. Clinical observations: brown/green coloured staining.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In an OECD 406 study conducted under GLP conditions Molyvan 855 produced a 0% (0/10) sensitisation rate and was found to be non-sensitiser to guinea pig skin.
Reference
Intradermal: Well defined erythema was noted at the intradermal induction sites of all test group animals at the 24 hr observation with very slight to well-defined erythema at the 48 hr observation. Very slight erythema was noted at the intradermal induction sites of all control group animals at the 24 and 48 hour observations.
Topical Induction: Brown/green coloured staining was noted at the induction sites of all test group animals at the 1 and 24 hour observations. The staining did not affect evaluation of skin responses. Well defined erythema with or without very slight to slight oedema was noted at the induction sites of all test group animals at the 1 hour observation. Very slight to well-defined erythema with or without very slight to slight oedema was noted at the induction sited of 8 test group animals at the 24 hr observation. Other skin reactions noted in test group animals were bleeding from the intradermal induction sites, hardened dark brown/black coloured scabs and small superficial scattered scabs. Adverse dermal reactions prevented accurate evaluation of erythema and oedema at the induction sites of two test group animals at 24 hr observation.
Bleeding from the intradermal induction sites was noted in two control group animals at the 1 -hr observation. No signs of erythema or oedema were noted at the treatment sites of control group animals at the 1 or 24 hr observation.
Topical Challenge: 75% v/v in Liquid Paraffin BP: Brown/green coloured staining was noted at the challenge sites of all test and control group animals at the 24 and 48 hr observations. The staining did not affect evaluation of skin responses. No skin reactions were noted at the Challenge sites of the test or control group animals at 24 or 48 hr observations.
50% v/v in Liquid Paraffin BP: Brown/green coloured staining was not described in the Table of observations at 24 and 48 hr observations. No skin reactions were noted at the Challenge sites of the test or control group animals at 24 or 48 hr observations.
Bodyweight gains were comparable to those observed in the control group animals over the same period.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Key study
In an OECD 406 study conducted under GLP conditions, using Dunkin-Hartley Guinea pigs, Molyvan 855 is not sensitiser (Safepharm Laboratories, 1997).
Migrated from Short description of key information:
In an OECD 406 study, Molyvan 855 (OD-855), produced a 0% (0/10) sensitisation rate and was found to be a non-sensitiser to guinea pig skin.
Justification for classification or non-classification
In an OECD 406 study, Molyvan 855 (OD-855), produced a 0% (0/10) sensitisation rate. In accordance with Regulation No. 1272/2008 (amended in Regulation No. 286/2011) Table 3.4.2, Molyvan 855 is therefore not classified as a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.